Inpharma Weekly

, Volume 1606, Issue 1, pp 11–11 | Cite as

Irinotecan + etoposide beneficial for ovarian cancer

Clinical study
  • 9 Downloads

Keywords

Platinum Ovarian Cancer Pilot Study Median Survival Partial Response 

Copyright information

© Adis International Ltd 2007

Personalised recommendations